Analysis

Mid-day market update: Nasdaq drops 200 points; Soliton shares spike higher

Midway through trading Monday, the Dow traded up 0.86% to 35,078.24 while the NASDAQ fell 1.5% to 13,546.64. The S&P also rose, gaining 0.01% to 4,233.22.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 32,708,020 cases with around 581,750 deaths. India confirmed a total of at least 22,662,570 cases and 246,110 deaths, while Brazil reported over 15,184,790 COVID-19 cases with 422,340 deaths. In total, there were at least 158,399,250 cases of COVID-19 worldwide with more than 3,294,610 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Consumer staples shares rose 1.4% on Monday. Meanwhile, top gainers in the sector included 22nd Century Group, Inc. XXII 5.28%, up 5%, and BellRing Brands, Inc. BRBR 5.63%, up 4%.

In trading on Monday, information technology shares fell 1.3%.

Top Headline

Tyson Foods, Inc. TSN 1.77% reported better-than-expected results for its second quarter.

Tyson Foods reported quarterly earnings of $1.34 per share, beating analysts’ estimates of $1.12 per share. The company’s quarterly sales came in at $11.30 billion, versus expectations of $11.19 billion.

Tyson Foods said it expects chicken results to be lower in FY21 versus FY20.

 

Equities Trading UP

Soliton, Inc. SOLY 24.61% shares shot up 24% to $22.30 following a $22.60 per share buyout from AbbVie Inc. AbbVie’s Allergan Aesthetics unit will pay $550 million in cash to scoop up Soliton and Resonic, its sound-wave device that improves the appearance of cellulite.

Shares of Precipio, Inc. PRPO 37.77% got a boost, shooting 22% to $4.69 after the company announced it launched a new, four-hour Acute Myeloid Leukemia HemeScreen panel to specifically determine the genetics of this aggressive, acute form of leukemia.

Cue Biopharma, Inc. CUE 27.62% shares were also up, gaining 34% to $15.08 as the company reported confirmed partial response in ongoing Phase 1 monotherapy study of CUE-101 in late stage second line and beyond patients with HPV+ recurrent/metastatic head and neck cancer.

Equities Trading DOWN

The Trade Desk, Inc. TTD 20.77% shares tumbled 20% to $528.32 after the company reported it is facing a period of higher uncertainty in its business outlook. The company’s board also declared a ten-for-one split in the form of a stock dividend.

Shares of Village Farms International, Inc. VFF 19.17% were down 18% to $9.11 after the company swung to a loss in the first quarter.

Insmed Incorporated INSM 20.87% was down, falling 17% to $26.95 after the company reported a proposed concurrent public offerings of $250 million of common stock and $500 million convertible senior notes due 2028. Morgan Stanley maintained Insmed with an Overweight and lowered the price target from $58 to $56.

Commodities

In commodity news, oil traded down 0.7% to $64.48, while gold traded up 0.3% to $1,837.20.

Silver traded down 0.1% Monday to $27.46 while copper fell 0.9% to $4.7055.

Euro zone

European shares were mostly lower today. The eurozone’s STOXX 600 slipped 0.04%, the Spanish Ibex Index rose 0.77% and the German DAX 30 slipped 0.13%. Meanwhile, the London’s FTSE 100 fell 0.24%, French CAC 40 fell 0.16% and Italy’s FTSE MIB gained 0.59%.

The UK’s Halifax house price index increased 8.2% year-over-year in April.

Economics

Federal Reserve Bank of Chicago President Charles Evans is set to speak at 2:00 p.m. ET.

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2024 FOREXSTREET S.L., All rights reserved.